Status:
NOT_YET_RECRUITING
Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections
Lead Sponsor:
Sohag University
Conditions:
Fecal Calprotectin in Intestinal Protozoa
Eligibility:
All Genders
Brief Summary
Calprotectin extracted from stool can be detected easily using ELISA. Numerous studies have shown that fecal calprotectin concentrations demonstrate a good correlation with intestinal inflammation Thi...
Eligibility Criteria
Inclusion
- 120 fecal samples will be collected as the following:
- 40 samples from patients complaining of gastrointestinal manifestations and only infected with B.hominis and E.histolytica.
- 40 samples from patients complaining of gastrointestinal manifestations without any protozoal infection.
- 40 healthy control cross-matched volunteers (without gastrointestinal manifestations, or intestinal parasites).
Exclusion
- persons received antiparasitic drugs or antibiotic 2 weeks before sample collection Patients with mixed intestinal protozoa Patients with intestinal protozoa rather than Entamoeba histolytica and Blastocystis
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06890455
Start Date
March 1 2025
End Date
February 1 2026
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt